ACHE and Parkinson disease: This perspective aligns with observations indicating that dopaminergic replacement treatment has no impact on gait and postural control in patients with PD, prompting a shift in research focus towards investigating the potential benefits of AChE inhibitors linked to cholinergic regulation [9, 28, 29].